These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5299222)

  • 21. Hemophilia in Sweden. Studies on demography of hemophilia and surgery in hemophilia and von Willebrand's disease.
    Larsson SA
    Acta Med Scand Suppl; 1984; 684():1-72. PubMed ID: 6611018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlled trial of oral contraceptives in haemophilia.
    Beck P; Bloom AL; Giddings JC; Sweetnam PM
    Br J Haematol; 1970 Dec; 19(6):667-73. PubMed ID: 4923835
    [No Abstract]   [Full Text] [Related]  

  • 24. [Enzyme immunoassay of factor VIII-related antigen with observation in patients with von Willebrand's disease and hemophilia A (author's transl)].
    Okuda T; Masuyama H; Tanigawa T; Narihiro N; Fujimura Y; Takase T; Mikami S; Yoshioka A; Fukui H
    Rinsho Ketsueki; 1980 Jul; 21(7):946-52. PubMed ID: 6775115
    [No Abstract]   [Full Text] [Related]  

  • 25. Factor VIII production and usage in Hungary.
    Elödi S; Hollán SR
    Scand J Haematol Suppl; 1984; 40():491-7. PubMed ID: 6433470
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of hemophilias].
    Fischer M; Deutsch E
    Dtsch Med J; 1968 Jul; 19(14):499-505. PubMed ID: 5305713
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical uses of plasma and plasma fractions: plasma-derived products for hemophilias A and B, and for von Willebrand disease.
    Josephson CD; Abshire TC
    Best Pract Res Clin Haematol; 2006; 19(1):35-49. PubMed ID: 16377540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical aspects of hemophilia and von Willebrand's disease.
    Ciavarella D; Counts RB
    Am J Med Technol; 1983 Dec; 49(12):850-4. PubMed ID: 6422754
    [No Abstract]   [Full Text] [Related]  

  • 29. Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism.
    Levesque H; Borg JY; Cailleux N; Vasse M; Daliphard S; Gancel A; Monconduit M; Courtois H
    Eur J Med; 1993 May; 2(5):287-8. PubMed ID: 8252160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with arginine vasopressin (DDAVP) in von Willebrand's disease and mild haemophilia.
    Ockelford PA; Menon NC; Berry EW
    N Z Med J; 1980 Nov; 92(672):375-8. PubMed ID: 6970907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion.
    Casonato A; Pontara E; Boscaro M; Dannhauser D; Sartori MT; Girolami A
    Haematologia (Budap); 1993; 25(1):57-67. PubMed ID: 8339998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Von Willebrand disease--type 2N (case report)].
    Zarnovicanová M; Pelikánová S
    Vnitr Lek; 2003 Apr; 49(4):319-21. PubMed ID: 12793057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leucocytosis following administration of cryoprecipitate.
    Mayne EE; Fitzpatrick J; Nelson SD
    Acta Haematol; 1970; 44(3):155-60. PubMed ID: 4991912
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of oral contraceptives on leukocyte count in hemophiliacs.
    Kiran O; Urkuten M; Ozsoylu S
    Clin Pediatr (Phila); 1970 Nov; 9(11):656-7. PubMed ID: 5477277
    [No Abstract]   [Full Text] [Related]  

  • 35. von Willebrand's factor and von Willebrand's disease.
    Matsushita T; Dong Z; Sadler JE
    Curr Opin Hematol; 1994 Sep; 1(5):362-8. PubMed ID: 9371306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of D-arginine vasopressin in von Willebrand's disease.
    Bala L; Boggio L; Green D
    Curr Hematol Rep; 2005 Jan; 4(1):1-2. PubMed ID: 15610653
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hemophilia and related diseases, with special reference to therapeutic policy].
    Nagao T
    Nihon Rinsho; 1974 May; 32(5):993-9. PubMed ID: 4603576
    [No Abstract]   [Full Text] [Related]  

  • 39. [Adenoidectomy and tonsillectomy in children with hemophilia and von Willebrand disease].
    Thach-Toan ; Gazengel C; François M; Torchet MF; Dautzenberg MD; Roulleau P
    Ann Otolaryngol Chir Cervicofac; 1985; 102(6):449-56. PubMed ID: 3879138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. von Willebrand's disease: from discovery to therapy - milestones in the last 25 years.
    Kreuz W
    Haemophilia; 2008 Nov; 14 Suppl 5():1-2. PubMed ID: 18786005
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.